Healthy volunteers needed to test new injection method for experimental drug
NCT ID NCT07560033
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests an experimental drug called CM326 in 192 healthy men aged 18 to 55. The goal is to see how the drug moves through the body and if it is safe when given through different injection devices. Participants will receive a single shot and be monitored for side effects and drug levels. This is an early-stage study with no direct treatment benefit.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY SUBJECTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Avocado at breakfast: a secret weapon for blood sugar and fullness?
- Sound waves as medicine: ultrasound may tame inflammation without drugs
- Broader pneumonia shield: new vaccine tested in children
- Scientists probe nerve signals to give prosthetics a sense of touch
- Healthy men test new drug to see if different factories make it the same
- New eye imaging study aims to map retinal disease progression